Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Melatonin + magnesium is a combination dietary supplement typically formulated to support sleep and relaxation. Melatonin is a hormone produced by the pineal gland, regulating circadian rhythm and promoting sleep onset by acting as an agonist at Melatonin receptor type 1 and type 2 in the central nervous system. Magnesium is an essential mineral that supports over 300 enzymatic reactions, including those related to muscle relaxation, neural transmission, and modulation of circadian timekeeping. Both components may have sleep-promoting effects: melatonin helps induce and regulate sleep, while magnesium may improve sleep quality and duration, potentially by enhancing endogenous melatonin synthesis and modulating GABAergic neurotransmission[1][3]. This combination is primarily indicated for insomnia and sleep disturbances, and clinical studies have shown it can significantly improve sleep quality compared to placebo[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on melatonin + magnesium.